Empresa Onconova Therapeutics Inc Nasdaq
Acciones
US68232V1089
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Oncology Therapeutics
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -.--% |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -.--% |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Steven Fruchtman
PSD | President | 73 | 19/01/15 |
Mark Guerin
DFI | Director of Finance/CFO | 55 | 01/09/13 |
Meena Arora
CTO | Chief Tech/Sci/R&D Officer | - | 24/10/23 |
Victor Moyo
CTO | Chief Tech/Sci/R&D Officer | - | 24/10/23 |
Matthew Parris
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
James Marino
BRD | Director/Board Member | 74 | 01/07/15 |
Jack Stover
BRD | Director/Board Member | 69 | 23/05/16 |
Mary Shoemaker
BRD | Director/Board Member | 63 | 01/04/20 |
Steven Fruchtman
PSD | President | 73 | 19/01/15 |
Trafford Clarke
BRD | Director/Board Member | 66 | 19/12/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 25 301 009 | 21 604 002 ( 85,39 %) | 0 | 85,39 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+29,03 % | 49,18 mil M | |
-0,10 % | 42,11 mil M | |
+43,45 % | 40,37 mil M | |
-5,26 % | 28,85 mil M | |
+11,48 % | 26,09 mil M | |
-22,74 % | 18,71 mil M | |
+9,06 % | 13,26 mil M | |
+30,01 % | 12,32 mil M | |
-1,51 % | 11,99 mil M |